Ionis Pharmaceuticals IONS Income before provision for income taxes
Income before provision for income taxes at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's income before provision for income taxes.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's income before provision for income taxes?
- Ionis Pharmaceuticals (IONS) reported income before provision for income taxes of -$92.31M in Q1 2026.
- How has Ionis Pharmaceuticals's income before provision for income taxes changed year-over-year?
- Ionis Pharmaceuticals's income before provision for income taxes increased by 37.1% year-over-year, from -$146.82M to -$92.31M.
- What is the long-term trend for Ionis Pharmaceuticals's income before provision for income taxes?
- Over 3 years (2022 to 2025), Ionis Pharmaceuticals's income before provision for income taxes has grown at a 13.7% compound annual growth rate (CAGR), from -$257.99M to -$379.6M.
- What does income before provision for income taxes mean?
- Measures the profit or loss generated by the company's ongoing business activities before accounting for income tax expenses. It provides a view of operational and financial performance excluding the impact of tax jurisdictions and tax planning strategies.